NEWSpublisher 2007 :: AngloChinese Investments
date from:
date to:
search for string:
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS » Contract Research Orgs » Shanghai ChemPartner Co.,Ltd.  1    
found files: 5
Shanghai ChemPartner Co.,Ltd. »25/04/2007 [Company watch]
Biotage, Chempartner sign multi-instrument deal

Shanghai Chempartner Co., Ltd., one of China’s leading contract research organizations (CRO), has invested in Biotage SP automated flash instruments and Initiator microwave synthesizers with delivery scheduled over the next 12 months. This is Biotage's largest single order in China at a value of $1.48 m....   more»

Shanghai ChemPartner Co.,Ltd. »30/10/2007 [Company watch]
ShangPharma Receives Strategic Investment from TPG

ShangPharma Corporation ("ShangPharma" or the "Group"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that leading global private investment firm TPG, through its TPG Growth Fund and TPG Biotech Fund (collectively known as "TPG"), has invested over US$30 million into the Group....   more»

Shanghai ChemPartner Co.,Ltd. »03/11/2007 [Company watch]
China drug R&D outsourcing firm mulls IPO

Shangpharma Corp, the second-largest pharmaceutical and biotechnology research outsourcing firm in China, is considering an initial public offering at a time when investors are lapping up Chinese stocks....   more»

Shanghai ChemPartner Co.,Ltd. »15/11/2007 [Company watch]
LEAD Therapeutics Announces Strategic Research Collaboration with ShangPharma

LEAD Therapeutics, Inc., a chemistry-driven drug discovery company based in the San Francisco Bay Area, today announced it has entered into a strategic research collaboration with Shanghai ChemPartner in China, the wholly owned subsidiary of ShangPharma. In conjunction with this collaboration, China Gateway Life Science (Holding) Ltd., the strategic investment arm of ShangPharma, has made an equity investment in LEAD Therapeutics. Previously announced investors include Pappas Ventures, ProQuest Investments, and Mustang Ventures....   more»

Shanghai ChemPartner Co.,Ltd. »07/01/2010 [Company watch]
Shanghai ChemPartner Places Third in Fast 50 China

Shanghai ChemPartner, as the flagship subsidiary of ShangPharma, a leading China-based Contract Research Organization (CRO), today announced it is a winner of the 2009 Deloitte Technology Fast 50 China, ranking 3rd on the list of the fastest-growing high tech companies in China. The award is a testament to ChemPartner\'s outstanding three-year revenue growth from 2006 to 2008....   more»

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.